Sharechat Logo

BIF acquires shares in Scentian Bio

Friday 18th August 2023

Text too small?

Scentian Bio operates in the bio sensor part of the information technologies sector. It specialises in rapid and objective detection of taste and smell factors, was formed in 2020, and is classified as seed stage, with its technology originating from Plant and Food Research.

 

BIF will make a cash investment of $200,000. Following this transaction (and issue of additional units to fund the purchase), Scentian Bio will represent 1.2% of BIF’s investment portfolio of over 30 companies, and with a net asset value of over $16.9 million.

 

Investors can continue to purchase units in BIF on the NZX or can subscribe for units in the fund as part of the process described in the fund’s Product Disclosure Statement (PDS) that is available at www.booster.co.nz

 

For further information regarding BIF visit https://www.booster.co.nz/booster-investments/booster-innovation-fund.aspx

 

For more information, please contact:

Gary Scott

Company Secretary

Booster Investment Management Limited

04 8944300

 

About Booster

Booster Investment Management Limited (Booster) is the manager and issuer of the Fund, and part of the Booster Group which has been helping New Zealanders save since 1998. The group currently administers superannuation and investment funds of over $5 billion on behalf of more than 190,000 New Zealanders.

BIF is a managed investment fund that invests in early-stage companies founded on intellectual property originated or developed in New Zealand.

For more information, including a copy of the Product Disclosure Statement, please visit www.booster.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

TWR - Capital Return - ATO Class Ruling Obtained
THL - FY25 Trading Update
April 17th Morning Report
EBOS announces opening of Retail Offer
MCY - FY2025 EBITDAF guidance revised to $760m
April 16th Morning Report
AIA - March 2025 Monthly traffic update
Ryman Healthcare FY25 full year results and webcast detail
CHI - Q1 2025 Operational Update
CNU - Q3 FY25 Connections Update